In our study, we found upregulation in the expression of MMP14 mRNA with discriminative cutoff values between NASH cases and the healthy control group that could also discriminate between NAFLD without steatosis, NAFLD with simple steatosis and NASH. This evidence concerns the gene MMP14 and metabolic dysfunction-associated steatotic liver disease.